Free Trial

Titan Medical (TMDIF) Competitors

Titan Medical logo
$0.37 +0.01 (+2.33%)
As of 08/11/2025

TMDIF vs. PROF, ELMD, LNSR, INFU, KRMD, TLSI, PDEX, RCEL, AVR, and LAKE

Should you be buying Titan Medical stock or one of its competitors? The main competitors of Titan Medical include Profound Medical (PROF), Electromed (ELMD), LENSAR (LNSR), InfuSystem (INFU), KORU Medical Systems (KRMD), TriSalus Life Sciences (TLSI), Pro-Dex (PDEX), Avita Medical (RCEL), Anteris Technologies Global (AVR), and Lakeland Industries (LAKE). These companies are all part of the "medical equipment" industry.

Titan Medical vs. Its Competitors

Titan Medical (NASDAQ:TMDIF) and Profound Medical (NASDAQ:PROF) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, earnings, analyst recommendations, institutional ownership, risk and valuation.

Profound Medical has a consensus target price of $11.00, indicating a potential upside of 98.56%. Given Profound Medical's stronger consensus rating and higher probable upside, analysts clearly believe Profound Medical is more favorable than Titan Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Titan Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Profound Medical
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Titan Medical has a net margin of 0.00% compared to Profound Medical's net margin of -269.35%. Profound Medical's return on equity of -70.41% beat Titan Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Titan MedicalN/A -82.31% -51.47%
Profound Medical -269.35%-70.41%-57.22%

0.0% of Titan Medical shares are held by institutional investors. Comparatively, 47.9% of Profound Medical shares are held by institutional investors. 0.0% of Titan Medical shares are held by company insiders. Comparatively, 1.5% of Profound Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Profound Medical had 8 more articles in the media than Titan Medical. MarketBeat recorded 8 mentions for Profound Medical and 0 mentions for Titan Medical. Profound Medical's average media sentiment score of 1.18 beat Titan Medical's score of 0.00 indicating that Profound Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Titan Medical Neutral
Profound Medical Positive

Titan Medical has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500. Comparatively, Profound Medical has a beta of 0.52, suggesting that its share price is 48% less volatile than the S&P 500.

Titan Medical has higher revenue and earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Titan Medical$17.63M2.38$6.95M$0.057.37
Profound Medical$10.68M15.59-$27.82M-$1.22-4.54

Summary

Profound Medical beats Titan Medical on 9 of the 16 factors compared between the two stocks.

Get Titan Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMDIF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMDIF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TMDIF vs. The Competition

MetricTitan MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$42.01M$78.71M$5.62B$9.84B
Dividend YieldN/AN/A4.61%4.07%
P/E Ratio-0.2910.2130.2925.74
Price / Sales2.3893.58463.41115.83
Price / Cash0.0218.4138.2159.48
Price / Book0.357.438.826.15
Net Income$6.95M-$26.39M$3.25B$265.06M
7 Day Performance10.35%3.24%4.05%2.80%
1 Month Performance1.88%4.82%4.32%1.68%
1 Year PerformanceN/A48.94%36.25%29.59%

Titan Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TMDIF
Titan Medical
N/A$0.37
+2.3%
N/A+929.1%$42.01M$17.63M-0.2950Gap Down
PROF
Profound Medical
2.6825 of 5 stars
$5.51
-1.3%
$11.00
+99.6%
-41.9%$165.58M$10.68M-4.52150News Coverage
Positive News
Earnings Report
Gap Down
ELMD
Electromed
1.0697 of 5 stars
$18.43
-1.0%
$33.50
+81.8%
+36.6%$154.55M$61.44M24.57160
LNSR
LENSAR
0.6778 of 5 stars
$13.03
-0.1%
$15.00
+15.1%
+211.2%$153.62M$53.49M-2.69110Earnings Report
INFU
InfuSystem
3.5696 of 5 stars
$7.17
+18.1%
$12.50
+74.3%
N/A$150.69M$137.58M119.52410
KRMD
KORU Medical Systems
1.9411 of 5 stars
$3.26
-0.6%
$4.63
+41.9%
+81.4%$150.42M$33.65M-29.6480Positive News
TLSI
TriSalus Life Sciences
3.0323 of 5 stars
$3.95
-6.2%
$10.75
+172.2%
-30.2%$149.47M$29.43M-3.53106News Coverage
Earnings Report
High Trading Volume
PDEX
Pro-Dex
3.2549 of 5 stars
$45.73
+1.4%
$56.00
+22.5%
+127.0%$147.04M$64.12M16.33140Positive News
RCEL
Avita Medical
1.4572 of 5 stars
$5.36
+1.5%
$16.50
+207.8%
-40.1%$141.67M$64.25M-2.45130News Coverage
Earnings Report
Analyst Forecast
AVR
Anteris Technologies Global
N/A$3.80
flat
$16.50
+334.2%
N/A$137.03M$2.70M0.00138News Coverage
Earnings Report
LAKE
Lakeland Industries
4.7847 of 5 stars
$13.93
-1.1%
$26.00
+86.6%
-35.0%$132.47M$167.21M-4.632,100Positive News

Related Companies and Tools


This page (NASDAQ:TMDIF) was last updated on 8/14/2025 by MarketBeat.com Staff
From Our Partners